| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |